I would start by saying that I'm not too sure the federal government can really hold provinces and territories or health care institutions or regional health authorities to account for what they do or do not do. What we can do is try to provide support.
I'll go back to the example of the use of psychoactive drugs among seniors in institutions. We support an organization called the Canadian Foundation for Healthcare Improvement. It has done a lot of the preliminary work looking at this issue of the overuse of medications among seniors in institutions. I think the best thing we can do, and it doesn't cost a whole lot of money, is to support that organization so that, with the model they may develop in a couple of jurisdictions, they get support to be able to roll that out and talk to people elsewhere in the country, and the spread effect takes place as quickly as possible. That's more what we can do.
On a larger scale, just to go back to the issue of drugs and access, for example, and universal access or not, one of the most important things we can do in our own backyard, and with provinces and territories, is to focus on the issue of drug prices and drug costs. Drug coverage, and expanding that coverage, will be limited if Canadian drug prices and total costs remain as high as they are today. That's a different approach. It's not an accountability approach, it's working with provinces, building on some of the things they're already doing, and using some of the levers we have to try to get drug prices to the point where there's actually money freed up to expand coverage, while still operating within the same total drug bill.
The best way for us to operate depends on what it is.